Thus, in ER positive (ER+) tumors, AR positivity is associated with reduced cell proliferation [6] and favorable clinicopathological features and prognoses [7], while in ER negative (ER-)/AR+ BC cases, it is generally accepted that AR promotes cell proliferation [8], although clinical studies have also reported contradictory results [9,10]. This evidence concerns the gene ESR1 and breast cancer.